TAM Receptor Inhibitors

Axl

Mer

Tyro3

TAM Receptor Inhibitors

Product Name	Axl	Mer	Tyro3	Purity
Cabozantinib	Axl			99.96%
Gilteritinib	Axl			99.69%
Bemcentinib	Axl			99.92%
2-D08	Axl			98.44%
LDC1267	Axl	Mer	Tyro3	99.58%
Dubermatinib	Axl			99.84%
UNC2250	Axl	Mer		99.92%
BMS 777607	Axl		Tyro3	99.33%
Zanzalintinib	Axl	Mer		99.73%
UNC2541		Mer		99.71%
Gilteritinib hemifumarate	Axl			99.75%
UNC569	Axl	Mer	Tyro3	99.87%
Tamnorzatinib	Axl	Mer	Tyro3	98.07%
Tilvestamab	Axl			98.08%
UNC5293	Axl		Tyro3
CEP-40783	Axl			99.12%
UNC1062	Axl		Tyro3	99.48%
SGI-7079	Axl			99.59%
Ningetinib	Axl			99.82%
Batiraxcept	Axl
UNC2881	Axl	Mer		99.79%
Enapotamab	Axl
NPS-1034	Axl			≥98.0%
Cabozantinib-d₆	Axl			98.14%
DS-1205b free base	Axl	Mer		99.92%
PROTAC Axl Degrader 2	Axl			98.01%
UNC4203	Axl		Tyro3	99.80%
RU-302	Axl			98.02%
AXL-IN-13	Axl			98.03%
Ningetinib Tosylate	Axl			99.59%
Mipasetamab	Axl
TL4830031	Axl			≥98.0%
AZ14145845	Axl	Mer
Cabozantinib hydrochloride	Axl
Axl-IN-6	Axl
Axl-IN-9	Axl
Axl-IN-11	Axl
PROTAC Axl Degrader 1	Axl
Axl-IN-4	Axl
Axl-IN-17	Axl, IC₅₀: 3.23 nM	Mer	Tyro3
Axl-IN-10	Axl
Bemcentinib (GMP)	Axl
HIV-IN-7	Axl
Axl/Mer/CSF1R-IN-1	Axl	Mer
Mecbotamab	Axl
PF-07265807	Axl	Mer	Tyro3
Axl-IN-12	Axl
Mipasetamab uzoptirine	Axl
AXL-IN-15	Axl
Axl-IN-7	Axl
Axl-IN-16	Axl
Axl-IN-8	Axl
Anticancer agent 109	Axl
Axl-IN-3	Axl
R916562	Axl
AXL-IN-14	Axl
Axl-IN-5	Axl

Name
Email *

	Sorry, but the email address you supplied was invalid.